Gene Mack - CEO, President, Director at Gain Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, President, Director
Stock Symbol
GANX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Gene Mack - trading volume in the past year for Gain Therapeutics, Inc.

Holdings reported by Gene Mack for Gain Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (right to buy) 271K $1.17M $5.86 Jan 6, 2025 Direct Common Stock
Common Stock 14.4K $14.5K $1.01 Aug 9, 2024 Direct
Employee Stock Option (right to buy) 200K Mar 20, 2025 Direct Common Stock

Transactions reported by Gene Mack for Gain Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.